Atnaujinta: 2024.07.06 18:03 (GMT+3)

SAN: Draft resolutions of the General Shareholders’ Meeting of 11 June 2005

2005.06.07, Sanitas, VLN
Sanitas AB                    Announcement                 07-06-2005

Draft resolutions of the General Shareholders’ Meeting of 11 June 2005

DRAFT RESOLUTIONS:
1. Change of the par value of the Company’s ordinary registered shares.

To change the par value of the Company’s ordinary registered shares
from LTL 5 to LTL 1 by splitting each share of LTL 5 par value into
five shares of LTL 1 par value to all shareholders.

2. Revocation of the pre-emption right to acquire shares of the new issue.

2.1. To revoke the pre-emption right to acquire shares of the new
issue of all Company’s shareholders.
2.2. To grant an exclusive right to acquisition and offering of all 2044 705
ordinary registered shares of LTL 1 (one) par value of the
new issue to the financial brokerage firm public company Finasta,
company code 1225 70630, registered at 23 Konstitucijos St., Vilnius.
2.3. The cause of the revocation of the pre-emption right is the fact
that, acting in accordance with the provisions of paragraph 1 of
Article 11 of the Law on Securities Market, the intermediary in
public trading of securities, i.e. the financial brokerage firm public
company Finasta, is granted the right to underwrite the initial public
offering of the shares.

3. Increase of the Company’s authorised capital from complementary
contributions.

To increase the Company’s authorised capital from complementary
monetary contributions in the amount of LTL 2 044 705, i.e. from
LTL 8 955 295 to LTL 11 000 000, by issuing 2 044 705 ordinary
registered shares of LTL 1 (one) par value and fixing the minimum
issue price per share at LTL 10. To authorise the Company’s
Director General to establish a detailed order of the public offering
of the new share issue.

4. Approval of the amendments and the new wording of the Company’s Articles
of Association.

4.1. To amend clause 5.1 of the Articles of Association as follows:
“5.1. The Company’s authorised capital is divided into 8 955 295
(eight million nine hundred fifty five thousand two hundred and
ninety five) ordinary registered shares. The par value per share is
LTL 1 (one).”
4.2. After provisions of clause 4.1 have been fulfilled and all shares
of the new issue fully subscribed for, to amend clause 5.1 of the
Company’s Articles of Association as follows:
“5.1. The Company’s authorised capital is divided into 11 000 000
(eleven million) ordinary registered shares. The nominal value per
share is LTL 1 (one).”
4.3. To authorise the Company’s Director General, Saulius
Jurgelėnas, to sign the amended Articles of Association of AB
“Sanitas” and other related documents, to register the amended
Articles of Association in the manner prescribed by the legal acts and
perform other actions related thereto. The Company’s Director
General is authorised, where not all shares are subscribed for within
the time period devoted for subscription of the shares, to increase the
Company’s authorised capital by the amount which is equal to the
aggregate par value of the shares subscribed for, making respective
changes in the size of the authorised capital and the number of the
shares, and submit the amended Articles of Associated to the
manager of the Register of Legal Entities”

DRAFT RESOLUTIONS
to be placed for discussion at the General Shareholders’ Meeting, in
the event the General Meeting resolves not to change the par value of
the ordinary registered shares of AB “Sanitas”:

2. Revocation of the pre-emption right to acquire shares of the new issue.

2.1. To revoke the pre-emption right to acquire shares of the new
issue of all Company’s shareholders.
2.2. To grant an exclusive right to acquisition and offering of 408941
ordinary registered shares of LTL 5 (five) par value of the new
issue to the financial brokerage firm public company Finasta,
company code 1225 70630, registered office at 23 Konstitucijos St.,
Vilnius.
2.3. The cause of the revocation of the pre-emption right is the fact
that, acting in accordance with the provisions of paragraph 1 of
Article 11 of the Law on Securities Market, the intermediary in
public trading of securities, i.e. the financial brokerage firm public
company Finasta, is granted the right to underwrite the initial public
offering of the shares.

3. Increase of the Company’s authorised capital from complementary
contributions.

To increase the Company’s authorised capital from complementary
monetary contributions in the amount of LTL 2 044 705, i.e. from
LTL 8 955 295 to LTL 11 000 000, by issuing 408 941 ordinary
registered shares of LTL 5 (five) par value and fixing the minimum
issue price per share at LTL 50. To authorise the Company’s
Director General to establish a detailed order of the public offering
of the new share issue.

4. Approval of amendments and the new wording of the Company’s Articles
of Association.

4.1. After all shares of the new issue have been fully subscribed for,
to amend clause 5.1 of the Company’s Articles of Association as follows:
“5.1. The Company’s authorised capital is divided into 2 200 000
(two million two hundred thousand) ordinary registered shares. The
nominal value per share is LTL 5 (five).”
4.2. To authorise the Company’s Director General, Saulius
Jurgelėnas, to sign the amended Articles of Association of AB
“Sanitas” and other related documents, to register the amended
Articles of Association in the manner prescribed by the legal acts and
perform other actions related thereto. The Company’s Director
General is authorised, where not all shares are subscribed for within
the time period devoted for subscription of the shares, to increase the
Company’s authorised capital by the amount which is equal to the
aggregate par value of the shares subscribed for, making respective
changes in the size of the authorised capital and the number of the
shares, and submit the amended Articles of Associated to the
manager of the Register of Legal Entities”

Sanitas AB
tel. (+370 37)22 67 25







Vertybiniai popieriai

Akcijos
Obligacijos
Fondai

Rinkos informacija

Statistika
Prekyba
Indeksai
Aukcionai

Reguliavimas

Taisyklės ir nuostatos
Priežiūra

Kaip pradėti

Įmonėms
Investuotojams
Nariams
First North sertifikuotiems PATARĖJAMS

Naujienos

Nasdaq naujienos
Emitento naujienos
Kalendorius

Apie mus

Nasdaq Baltijos rinkoje
Biurai